6533b7dbfe1ef96bd126fc91
RESEARCH PRODUCT
Liraglutide reduces postprandial hyperlipidaemia by increasing apoB48 catabolism and by reducing apoB48 production
B VergèsLaurence DuvillardBenjamin BouilletSabine Baillot-rudoniP. BuffierE. CrevisyJ-m Petitsubject
[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismliraglutideapoB48Diabetic dyslipidemiaPostprandial hyperlipidemiaGLP1 agonist[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismdescription
IF 6.080; International audience
year | journal | country | edition | language |
---|---|---|---|---|
2016-09-12 |